Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/25/24 20:54 | 9/23/24 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 2 | S.d | -359 | 102.51 | 0 | -4 | 23 | D | |||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 1 | S | -133 | 103.94 | 0 | -1 | 25 | D | |||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | 2 | S.dm | -3,629 | 103.96 | 0 | -35 | 51 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |